Rapid Multiplexed Immunoassay for Detection of Antibodies to Kaposi's Sarcoma-Associated Herpesvirus.
Diagnosis of KSHV-infected individuals remains a challenge. KSHV prevalence is high in several populations with high prevalence of HIV, leading to increased risk of development of Kaposi's sarcoma (KS). While current assays are reliable for detecting antibodies to KSHV, none are routinely utili...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2016-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC5036886?pdf=render |
| _version_ | 1818940917777694720 |
|---|---|
| author | Cathy Logan Kathryn Todorof Suzanne P Fiorillo Thomas B Campbell John H Elder Margaret Borok Ivy Gudza Lovemore Gwanzura Buxton Ndemera Michael J Lochhead Constance A Benson Robert T Schooley |
| author_facet | Cathy Logan Kathryn Todorof Suzanne P Fiorillo Thomas B Campbell John H Elder Margaret Borok Ivy Gudza Lovemore Gwanzura Buxton Ndemera Michael J Lochhead Constance A Benson Robert T Schooley |
| author_sort | Cathy Logan |
| collection | DOAJ |
| description | Diagnosis of KSHV-infected individuals remains a challenge. KSHV prevalence is high in several populations with high prevalence of HIV, leading to increased risk of development of Kaposi's sarcoma (KS). While current assays are reliable for detecting antibodies to KSHV, none are routinely utilized to identify individuals with KSHV infection and thus at increased risk for KS due to assay complexity, lack of access to testing, and cost, particularly in resource-limited settings. Here we describe the addition of KSHV proteins LANA and K8.1 to a previously evaluated HIV/co-infection multiplexed fluorescence immunoassay system. This study demonstrates assay performance by measuring antibody reactivity for KSHV and HIV-1 in a collection of clinical specimens from patients with biopsy-proven KS and sourced negative controls. The KSHV assay correctly identified 155 of 164 plasma samples from patients with biopsy-proven KS and 85 of 93 KSHV antibody (Ab)-negative samples for a sensitivity of 95.1% and specificity of 91.4%. Assay performance for HIV-1 detection was also assessed with 100% agreement with independently verified HIV-1 Ab-positive and Ab-negative samples. These results demonstrate good sensitivity and specificity for detection of antibody to KSHV antigens, and demonstrate the potential for multiplexed co-infection testing in resource-limited settings to identify those at increased risk for HIV-1-related complications. |
| first_indexed | 2024-12-20T06:47:16Z |
| format | Article |
| id | doaj.art-8238fab5d5d54c87bd0662e4ab4122e0 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-20T06:47:16Z |
| publishDate | 2016-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-8238fab5d5d54c87bd0662e4ab4122e02022-12-21T19:49:40ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01119e016361610.1371/journal.pone.0163616Rapid Multiplexed Immunoassay for Detection of Antibodies to Kaposi's Sarcoma-Associated Herpesvirus.Cathy LoganKathryn TodorofSuzanne P FiorilloThomas B CampbellJohn H ElderMargaret BorokIvy GudzaLovemore GwanzuraBuxton NdemeraMichael J LochheadConstance A BensonRobert T SchooleyDiagnosis of KSHV-infected individuals remains a challenge. KSHV prevalence is high in several populations with high prevalence of HIV, leading to increased risk of development of Kaposi's sarcoma (KS). While current assays are reliable for detecting antibodies to KSHV, none are routinely utilized to identify individuals with KSHV infection and thus at increased risk for KS due to assay complexity, lack of access to testing, and cost, particularly in resource-limited settings. Here we describe the addition of KSHV proteins LANA and K8.1 to a previously evaluated HIV/co-infection multiplexed fluorescence immunoassay system. This study demonstrates assay performance by measuring antibody reactivity for KSHV and HIV-1 in a collection of clinical specimens from patients with biopsy-proven KS and sourced negative controls. The KSHV assay correctly identified 155 of 164 plasma samples from patients with biopsy-proven KS and 85 of 93 KSHV antibody (Ab)-negative samples for a sensitivity of 95.1% and specificity of 91.4%. Assay performance for HIV-1 detection was also assessed with 100% agreement with independently verified HIV-1 Ab-positive and Ab-negative samples. These results demonstrate good sensitivity and specificity for detection of antibody to KSHV antigens, and demonstrate the potential for multiplexed co-infection testing in resource-limited settings to identify those at increased risk for HIV-1-related complications.http://europepmc.org/articles/PMC5036886?pdf=render |
| spellingShingle | Cathy Logan Kathryn Todorof Suzanne P Fiorillo Thomas B Campbell John H Elder Margaret Borok Ivy Gudza Lovemore Gwanzura Buxton Ndemera Michael J Lochhead Constance A Benson Robert T Schooley Rapid Multiplexed Immunoassay for Detection of Antibodies to Kaposi's Sarcoma-Associated Herpesvirus. PLoS ONE |
| title | Rapid Multiplexed Immunoassay for Detection of Antibodies to Kaposi's Sarcoma-Associated Herpesvirus. |
| title_full | Rapid Multiplexed Immunoassay for Detection of Antibodies to Kaposi's Sarcoma-Associated Herpesvirus. |
| title_fullStr | Rapid Multiplexed Immunoassay for Detection of Antibodies to Kaposi's Sarcoma-Associated Herpesvirus. |
| title_full_unstemmed | Rapid Multiplexed Immunoassay for Detection of Antibodies to Kaposi's Sarcoma-Associated Herpesvirus. |
| title_short | Rapid Multiplexed Immunoassay for Detection of Antibodies to Kaposi's Sarcoma-Associated Herpesvirus. |
| title_sort | rapid multiplexed immunoassay for detection of antibodies to kaposi s sarcoma associated herpesvirus |
| url | http://europepmc.org/articles/PMC5036886?pdf=render |
| work_keys_str_mv | AT cathylogan rapidmultiplexedimmunoassayfordetectionofantibodiestokaposissarcomaassociatedherpesvirus AT kathryntodorof rapidmultiplexedimmunoassayfordetectionofantibodiestokaposissarcomaassociatedherpesvirus AT suzannepfiorillo rapidmultiplexedimmunoassayfordetectionofantibodiestokaposissarcomaassociatedherpesvirus AT thomasbcampbell rapidmultiplexedimmunoassayfordetectionofantibodiestokaposissarcomaassociatedherpesvirus AT johnhelder rapidmultiplexedimmunoassayfordetectionofantibodiestokaposissarcomaassociatedherpesvirus AT margaretborok rapidmultiplexedimmunoassayfordetectionofantibodiestokaposissarcomaassociatedherpesvirus AT ivygudza rapidmultiplexedimmunoassayfordetectionofantibodiestokaposissarcomaassociatedherpesvirus AT lovemoregwanzura rapidmultiplexedimmunoassayfordetectionofantibodiestokaposissarcomaassociatedherpesvirus AT buxtonndemera rapidmultiplexedimmunoassayfordetectionofantibodiestokaposissarcomaassociatedherpesvirus AT michaeljlochhead rapidmultiplexedimmunoassayfordetectionofantibodiestokaposissarcomaassociatedherpesvirus AT constanceabenson rapidmultiplexedimmunoassayfordetectionofantibodiestokaposissarcomaassociatedherpesvirus AT roberttschooley rapidmultiplexedimmunoassayfordetectionofantibodiestokaposissarcomaassociatedherpesvirus |